These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 2058817)

  • 1. Measurement of PC20 histamine with the use of two different nebulizers and measurement of FEV1 and PEF.
    Iversen M; Harving H; Pedersen B
    Allergy; 1991 Apr; 46(3):213-6. PubMed ID: 2058817
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of the provocative concentration of methacholine causing a 20% fall in FEV1 between the AeroEclipse II breath-actuated nebulizer and the wright nebulizer in adult subjects with asthma.
    El-Gammal AI; Killian KJ; Scime TX; Beaudin S; Schlatman A; Cockcroft DW; Gauvreau GM
    Ann Am Thorac Soc; 2015 Jul; 12(7):1039-43. PubMed ID: 25871542
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Testing bronchial hyper-responsiveness: provocation or peak expiratory flow variability?
    den Otter JJ; Reijnen GM; van den Bosch WJ; van Schayck CP; Molema J; van Weel C
    Br J Gen Pract; 1997 Aug; 47(421):487-92. PubMed ID: 9302787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between airway responsiveness and peak expiratory flow variability in subjects with allergic rhinitis.
    Prieto L; Gutiérrez V; Bertó JM; Tornero C; Camps B; Pérez MJ
    Ann Allergy Asthma Immunol; 1995 Sep; 75(3):273-9. PubMed ID: 7552931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison between peak expiratory flow and forced expiratory volume in one second (FEV1) during bronchoconstriction induced by different stimuli.
    Giannini D; Paggiaro PL; Moscato G; Gherson G; Bacci E; Bancalari L; Dente FL; Di Franco A; Vagaggini B; Giuntini C
    J Asthma; 1997; 34(2):105-11. PubMed ID: 9088296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Provocative dose of methacholine causing a 20% drop in FEV1 should be used to interpret methacholine challenge tests with modern nebulizers.
    Dell SD; Bola SS; Foty RG; Marshall LC; Nelligan KA; Coates AL
    Ann Am Thorac Soc; 2015 Mar; 12(3):357-63. PubMed ID: 25575246
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of histamine bronchial challenges with the Wright nebulizer and the dosimeter.
    Beaupré A; Malo JL
    Clin Allergy; 1979 Nov; 9(6):575-83. PubMed ID: 519838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased bronchial responsiveness to histamine associated with shortened inhalation time.
    Vázquez C; Rodríguez-Soriano J
    Pediatr Pulmonol; 1989; 6(2):99-102. PubMed ID: 2927976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Methacholine Challenge Testing: A Novel Method for Measuring PD
    Davis BE; Simonson SK; Blais CM; Cockcroft DW
    Chest; 2017 Dec; 152(6):1251-1257. PubMed ID: 28923758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rapid dosimetric method with controlled tidal breathing for histamine challenge. Repeatability and distribution of bronchial reactivity in a clinical material.
    Sovijärvi AR; Malmberg LP; Reinikainen K; Rytilä P; Poppius H
    Chest; 1993 Jul; 104(1):164-70. PubMed ID: 8325062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of serial monitoring of peak expiratory flow and FEV1 in the diagnosis of occupational asthma.
    Leroyer C; Perfetti L; Trudeau C; L'Archevĕque J; Chan-Yeung M; Malo JL
    Am J Respir Crit Care Med; 1998 Sep; 158(3):827-32. PubMed ID: 9731012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methacholine Challenge: Comparison of Airway Responsiveness Produced by a Vibrating Mesh Nebulizer Versus a Jet Nebulizer.
    Blais CM; Cockcroft DW; Veilleux J; Boulay MÈ; Boulet LP; Gauvreau GM; Scime TX; Watson RM; O'Byrne PM; Davis BE
    J Aerosol Med Pulm Drug Deliv; 2018 Apr; 31(2):88-93. PubMed ID: 28813613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of responsiveness to inhaled histamine using FEV1: comparison of PC20 and threshold.
    Cockcroft DW; Berscheid BA; Murdock KY
    Thorax; 1983 Jul; 38(7):523-6. PubMed ID: 6612638
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Standardization of inhalation provocation tests. Dose vs concentration of histamine.
    Cockcroft DW; Berscheid BA
    Chest; 1982 Nov; 82(5):572-5. PubMed ID: 7128223
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bronchial challenge, assessed with forced expiratory manoeuvres and airway impedance.
    Broeders ME; Molema J; Hop WC; Folgering HT
    Respir Med; 2005 Aug; 99(8):1046-52. PubMed ID: 15950147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative amount of albuterol delivered to lung receptors from a metered-dose inhaler and nebulizer solution. Bioassay by histamine bronchoprovocation.
    Blake KV; Hoppe M; Harman E; Hendeles L
    Chest; 1992 Feb; 101(2):309-15. PubMed ID: 1310456
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reproducibility of histamine challenge tests in asthmatic children.
    Hariparsad D; Wilson N; Dixon C; Silverman M
    Thorax; 1983 Apr; 38(4):258-60. PubMed ID: 6867976
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Value of the peak expiratory flow in bronchodynamic tests.
    Pino JM; García-Río F; Prados C; Alvarez-Sala R; Díaz S; Villasante C; Villamor J
    Allergol Immunopathol (Madr); 1996; 24(2):54-7. PubMed ID: 8933890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of results of histamine challenge.
    Reiser J; Wadsworth J; Nunn A; Warner JO
    Pediatr Pulmonol; 1989; 6(4):242-5. PubMed ID: 2748219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol inhalation challenge in relation to histamine response in children with asthma.
    Gerritsen J; Koëter GH; Vander Weele LT; Knol K
    Thorax; 1988 Jun; 43(6):451-5. PubMed ID: 2971275
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.